Thiogenesis Therapeutics Future Growth
Future criteria checks 0/6
Thiogenesis Therapeutics is forecast to grow revenue at 75.7% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 36.6% |
| Revenue growth rate | 75.7% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 11 Jan 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 57 | N/A | N/A | 39 | 1 |
| 12/31/2025 | N/A | N/A | N/A | -8 | 1 |
| 12/31/2024 | N/A | N/A | N/A | -8 | 1 |
| 12/31/2023 | N/A | -5 | -3 | -3 | N/A |
| 9/30/2023 | N/A | -3 | -3 | -3 | N/A |
| 6/30/2023 | N/A | -3 | -2 | -2 | N/A |
| 3/31/2023 | N/A | -3 | -3 | -3 | N/A |
| 12/31/2022 | N/A | -4 | -2 | -2 | N/A |
| 9/30/2022 | N/A | -4 | -2 | -2 | N/A |
| 6/30/2022 | N/A | -3 | -1 | -1 | N/A |
| 3/31/2022 | N/A | -3 | -1 | -1 | N/A |
| 12/31/2021 | N/A | -1 | -1 | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if TTI's forecast earnings growth is above the savings rate (2.1%).
Earnings vs Market: Insufficient data to determine if TTI's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if TTI's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: TTI is forecast to have no revenue next year.
High Growth Revenue: TTI is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if TTI's Return on Equity is forecast to be high in 3 years time